Trillions of commensal microbes live in our body, the majority in the gut. This gut microbiota is in constant interaction with the homeostatic systems, the nervous, immune and endocrine systems, being fundamental for their appropriate development and function as well as for the neuroimmunoendocrine communication. The health state of an individual is understood in the frame of this communication, in which the microbiota-gut-brain axis is a relevant example. This bidirectional axis is constituted in early age and is affected by many environmental and lifestyle factors such as diet and stress, among others, being involved in the adequate maintenance of homeostasis and consequently in the health of each subject and in his/her rate of aging. For this, an alteration of gut microbiota, as occurs in a dysbiosis, and the associated gut barrier deterioration and the inflammatory state, affecting the function of immune, endocrine and nervous systems, in gut and in all the locations, is in the base of a great number of pathologies as those that involve alterations in the brain functions. There is an age-related deterioration of microbiota and the homeostatic systems due to oxi-inflamm-aging, and thus the risk of aging associated pathologies such as the neurodegenerative illness. Currently, this microbiota-gut-brain axis has been considered to have a relevant role in the pathogenesis of Alzheimer’s disease and represents an important target in the prevention and slowdown of the development of this pathology. In this context, the use of probiotics seems to be a promising help.
MargollesA, SuarezJE (2020) The human microbiota: General concepts, composition, distribution and functions. Approach Aging Control24, 8–16.
2.
IllianoP, BrambillaR, ParolineC (2020) The mutual interplay of gut microbiota, diet and human disease. FEBS J287, 833–855.
3.
AltvesS, YildizHK, VuralHC (2020) Interaction of the microbiota with the human body in health and diseases. Biosci Microbiota Food Health39, 23–32.
4.
KunduP, BlacherE, ElinavE, PetterssonS (2017) Our gut microbiome: The evolving inner self. Cell171, 14811493.
5.
BesedovskyHO, Del ReyA (2007) Physiology of psychoneuroimmunology: A personal view. Brain Behav Immun21, 34–44.
6.
De la FuenteM (2018) Bio-psycho-social bridge: The psychoneuroimmune system in successful aging. In Cambridge Handbook of Succesful Aging, Fernández-Ballesteros R, Benetos A, Robine JM, eds. Cambridge University Press, New York, pp. 265-280.
7.
Del ReyA, BesedovskyHO (2017) Immune-neuro-endocrine reflexes, circuits, and networks: Physiologic and evolutionary implications. Front Horm Res48, 1–18.
8.
De la FuenteM (2018) Oxidation and inflammation in the immune and nervous systems, a link between aging and anxiety. In Handbook of Immunosenescence, Fulop T, Franceschi C, Hirokawa K, Pawelec G, eds. Springer Nature, Cham, pp. 1-31.
9.
BesedovskyHO (2019) The immune system as a sensorial system that can modulate brain functions and reset homeostasis. Ann N Y Acad Sci1437, 5–14.
10.
NettisMA, ParianteCM (2020) Is there neuroinflammation in depression? Understanding the link between the brain and the peripheral immune system in depression. Int Rev Neurobiol152, 23–40.
11.
MüllerN (2020) A brief history of immunological research into psychosis and pathways for immune influence of the brain. Curr Top Behav Neurosci44, 1–8.
12.
RaonyI, de FigueiredoCS, PandolfoP, Giestal-de-AraujoE, Oliveira-Silva BomfinP, SavinoW (2020) Psycho-neuroendocrine-Immune interactions in covid-19: Potential impacts on mental health. Front Immunol11, 1170.
De la FuenteM (2020) Interactions between the gut microbiota and the nervous system. Microbiota-gut-brain axis in health and mental disease. Approach Aging Control24, 65–81.
22.
ParkerA, FonsecaS, CardingSR (2020) Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes11, 135–157.
23.
RoagerHM, LinchtTR (2018) Microbial tryptophan catabolites in health and disease. Nat Commun9, 3294–3304.
24.
de MelloVD, PaananenJ, LindströmJ, LankinenMA, ShiL, KuusistoJ, PihlajamäkiJ, AuriolaS, LehtonenM, RolandssonO, BergdahlIA, NordinE, Ilanne-ParikkaP, Keinänen-KiukaanniemiS, LandbergR, ErikssonJG, TuomilehtoJ, HanhinevaK, UusitupaM (2017) Indolepropionic acid and novel lipid metabolites are associates with a lower risk of type 2 diabetes in the Finnish diabetes prevention study. Sci Rep7, 46337–46350.
25.
BainCC, CerovicV (2020) Interactions of the microbiota with de mucosal immune system. Immunology159, 1–3.
26.
Ganal-VonarburgSC, DuerrCU (2020) The interaction of intestinal microbiota and innate lymphoid cells in health and disease throughout life. Immunology159, 39–51.
27.
LiM, van EschBCAM, WagenaarGTM, GarssenJ, FolkertsG, HenricksAJ (2018) Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol831, 52–59.
28.
WangG, HuangS, WangY, CalS, YuH, LluH, ZengX, ZhangG, QlaoS (2019) Bridging intestinal immunity and gut microbiota by metabolites. Cell Mol Life Sci76, 3917–3937.
29.
NegiS, DasDK, PahariS, NadeemS, AgrewalaJN (2019) Potential role of gut microbiota in induction and regulation of innate immune memory. Front Immunol10, 2441.
30.
KnausUG, HertzbergerR, PircalabioruGG, YousefiSP, Branco Dos SantosF (2017) Pathogen control at the intestinal mucosa-H2O2 to the rescue. Gut Microbes8, 67–74.
31.
AmenyogbeN, KollmannTR, Ben-OthmanR (2017) Early-life host-microbiome interphase: The key frontier for immune development. Fronti Pediatr5, 111.
32.
Al NabhaniZ, EberlG (2020) Imprinting of the immune system by the microbiota early in life. Mucosal Immunol13, 183–189.
33.
AhlawatS, Asha, SharmaKK (2020) Gut-organ axis: A microbial outreach and networking. Lett Appl Microbiol, doi:10.1111/lam.13333.
34.
FernandesMF, de OliveiraS, PortovedoM, Brito-RodriguesP, Ramirez-VinoloMA (2020) Effects of short chain fatty acids on age-related disorders. Adv Exp Med Biol1260, 85–105.
35.
Aresti-SanzJ, El AideyS (2019) Microbiota and gut neuropeptides: A dual action of antimicrobial activity and neuroimmune response. Psychopharmacology (Berl)236, 1597–1609.
36.
EltokniA, JanmaatIE, GenediM, HaarmanBCM, SommerIEC (2020) Dysregulation of synaptic pruning as a possible link between intestinal microbiota dysbiosis and neuropsychiatric disorders. J Neurosci Res98, 1335–1369.
37.
BusnelliM, ManziniS, ChiesaG (2019) The gut microbiota affects host pathophysiology as an endocrine organ: A focus on cardiovascular disease.. Nutrients12, 79.
38.
WilliamsCL, Garcia-ReyeroN, MartyniukCJ, TubbsCW, BisesiJHJr (2020) Regulation of endocrine systems by the microbiome: Perspectives from comparative animal models. Gen Comp Endocrinol292, 113437.
39.
FungTC (2020) The microbiota-immune axis as a central mediator of gut-brain communication. Neurobiol Dis136, 104714.
40.
DalileB, Van OudenhoveL, VervlietB, VerbekeK (2019) The role of short-chain fatty acids in microbiota-gut-brain communication.. Nat Rev Gastroenterol Hepatol16, 461–478.
41.
HeyckM, IbarraA (2019) Microbiota and memory: A symbiotic therapy to counter cognitive decline?Brain Circ5, 124–129.
42.
MüngerE, Montiel-CastroAJ, LanghansW, Pacheco-LopezG (2018) Reciprocal interactions between gut microbiota and host social behavior. Front Integr Neurosci12, 21.
43.
SherwinE, BordensteinSR, QuinnJL, DinanTG, CryanJF (2019) Microbiota and the social brain. Science366, 6465.
44.
PapadopoulosZ, HerzJ, KipnisJ (2020) Meningela lymphatics: From anatomy to central nervous system immune surveillance. J Immunol204, 286–293.
45.
GubertC, KongG, RenoirT, HannanAJ (2020) Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases. Neurobiol Dis134, 104621.
46.
PanduroA, Rivera-IñiguezI, Sepulveda-VillegasM, RomanS (2017) Gens, emotions and gut microbiota: The next frontier for the gastroenterologist. World J Gastroenterol23, 3030–3042.
47.
RojoD, Méndez-GarcíaC, RaczkowskaBA, BargielaR, MoyaA, FerrerM, BarbasC (2017) Exploring the human microbiome from multiple perspectives: Factors altering its composition and function. FEMS Microbiol Rev41, 453–78.
PistollatoF, CanoSS, ElioI, VergaraMM, GiampieriF, BattinoM (2016) Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr Rev74, 624–634.
50.
DumitrescuL, Popescu-OlaruI, CozmaL, TulbaD, HinescuME, CeafalanLC, GherghiceanuM, PopescuBO (2018) Oxidative stress and the microbiota-gut-brain axis. Oxid Med Cell Long2018, 2406594.
51.
NeedhamBD, Kaddurah-DaoukR, MazmanianSK (2020) Gut microbial molecules in behavioural and neurodegenerative conditions. Nat Rev Neurosci21, 717–731.
52.
HasanN, YangH (2019) Factors affecting the composition of the gut microbiota, and its modulation. Peer J7, e7502.
Al RubayeH, AdamsonChC, JadavjiNM (2020) The role of maternal diet on offspring gut microbiota development: A review. J Neurosci Res99, 284–293.
55.
TurroniF, MilaniC, DurantiS, LugliGA, BernasconiS, MargollesA, Di PierroF, van SinderenD, Ventura (2020) The infant gut microbioma as a microbial organ influencing host well-being. Ital J Pediatr46, 16.
56.
DonovanSM (2020) Evolution of the gut microbiome in infancy within an ecological context. Curr Opin Clin Nutr Metab Care23, 223–227.
57.
MoszakM, SzulinskaM, BogdanskiP (2020) You are what you eat-The relationship between diet, microbiota, and metabolic disorders-A review. Nutrients12, 1096.
58.
BarN, KoremT, WeissbrodO, ZeeviD, RothschildD, LeviatanS, KosowerN, Lotan-PompanM, WeinbergerA, Le RoyCI, MenniC, ViscontiA, FalchiM, SpectorTD, IMI DIRECT consortium; AdamskiJ, FranksPW, PedersenO, SegalE (2020) A reference map of potential determinants for the human serum metabolome. Nature588, 135–140.
59.
FrameLA, CostaE, JacksonSA (2020) Current explorations of nutrition and the gut microbiome: A comprehensive. Evaluation of the review literature. Nutr Rev78, 798–812.
60.
WanMLY, CoVA, El-NezamiH (2020) Dietary polyphenol impact on gut health and microbiota. Crit Rev Food Sci Nutr25, 1–22.
RayA, GulatiK, RaiN (2017) Stress, anxiety, and immunomodulation: A pharmacological analysis. Vitam Horm103, 1–25.
63.
Molina-TorresG, Rodriguez-ArrastiaM, RomanP, Sanchez-LabracaN, CardonaD (2019) Stress and the gut-microbiota-brain axis. Behav Pharmacol30, 187–200.
64.
LabanskiA, LanghorstJ, EnglerH, ElsenbruchS (2020) Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases: A transdisciplinary challenge. Psychoneuroendocrinology111, 104501.
65.
FrankiensztajnLM, ElliotE, KorenO (2020) The microbiota and the hypothalamus-pituitary-adrenocortical (HPA) axis, implications for anxiety and stress disorders. Curr Opin Neurobiol62, 76–82.
66.
PilmisB, Le MonnierA, ZaharJR (2020) Gut microbiota, antibiotic therapy and antimicrobial resistance: A narrative review. Microorganinsms8, 269.
67.
HaoWZ, LiXJ, ZhangPW, ChenJX (2020) A review of antibiotics, depression, and the gut microbiome. Psychiatry Res284, 112691.
68.
VangoitsenhovenR, CresciGAM (2020) Role of microbiome and antibiotics in autoimmune diseases. Nutr Clin Pract35, 406–416.
69.
KimH, SitarikAR, WoodcroftK, JohnsonCC, ZorattiE (2019) Birth mode, breastfeeding, pet exposure, and antibiotic use: Associations with the gut microbiome and sensitization in children. Curr Allergy Asthma Rep19, 22.
70.
MurakamiM, TogniniP (2020) The circadian clock as an essential molecular link between host physiology and microorganisms.. Front Cell Infect Microbiol9, 469–479.
71.
YahfoufiN, MatarCh, IsmailN (2020) Adolescence and aging: Impact of adolescence inflammatory stress and microbiota alterations on brain development, aging, and neurodegeneration. J Gerontol A Biol Sci Med Sci75, 1251–1257.
72.
BanaB, CabreiroF (2019) The microbiome and aging. Ann Rev Genet53, 239–261.
73.
HarmanD (1956) Ageing: A theory based on free radical and radiation chemistry. J Gerontol2, 298–230.
74.
De la FuenteM, MiquelJ (2009) An update of the oxidation-inflammation theory of aging. The involvement of the immune system in oxi-inflamm-aging. Current Pharm Des15, 3003–3026.
75.
Martinez de TodaI, MateI, VidaC, CrucesJ, De la FuenteM (2016) Immune function parameters as markers of biological age and predictors of longevity. Aging8, 3110–3119.
76.
Martinez de TodaI, VidaC, GarridoA, De la FuenteM (2020) Redox parameters as markers of the rate of aging and predictors of lifespan. J Gerontol A Biol Sci Med Sci75, 613–620.
77.
EricksonMA, BanksWA (2019) Age-associated changes in the immune system and blood-brain barrier functions. Int J Mol Sci20, 1632.
78.
SalazarN, GonzálezS, NogackaAM, Rios-CoviánD, ArboleyaS, GueimondeM, Reyes-GavilánCGL (2020) Microbiome: Effects of ageing and diet. Curr Issues Mol Biol36, 33–62.
79.
De la FuenteM, Diaz-Del CerroE, SalazarN, GueimondeM (2020) Microbiota and probiotics in aging. Approach Aging Control24, 127–142.
80.
BufordTW (2020) The gut microbiome and aging. J Gerontol A Biol Sci Med Sci75, 1229–1231.
81.
KimS, JazwinskiSM (2018) The gut microbiota and healthy aging: A mini review. Gerontology64, 513–520.
82.
FinlayBB, PettersonS, MelbyMK, BoschTCG (2019) The microbiome mediates environmental effects on aging. Bioessays41, e1800257.
83.
KomanduriM, GondaliaS, ScholeyA, StoughC (2019) The microbiome and cognitive aging: A review of mechanisms. Psychopharmacology236, 1559–1571.
84.
MaynardC, WeinkoveD (2018) The gut microbiota and ageing. Subcell Biochem90, 351–371.
85.
CătoiAF, CorinaA, KatsikiN, VodnarDC, AndreicutAD, StoianAP, RizzoM, Pérez-MartínezP (2020) Gut microbiota and aging-A focus on centenarians. Biochim Biophys Acta Mol Basis Dis1866, 165765.
86.
BadalVD, VaccarielloED, MurrayER, YuKE, KnightR, JesteDV, NguyenTT (2020) The gut microbiome, aging, and longevity: A systematic review. Nutrients12, 3759–3784.
87.
Martinez de TodaI, VidaC, García-SalmonesM, Alonso-FernándezP, De la FuenteM (2020) Immune function, oxidative and inflammatory markers in centenarians as potential predictors of survival and indicators of recovery after hospital admission. J Gerontol A Biol Sci Med Sci75, 1827–1833.
88.
OsorioC, KanukuntlaT, DiazE, JafriN, CummingsM (2019) The post-amyloid era in Alzheimer’s disease: Trust your gut feeling. Front Aging Neurosci11, 143.
89.
MatéI, CrucesJ, Gimenez-LlortL, De la FuenteM (2015) Function and redox state of peritoneal leukocytes as preclinical and prodromic markers in a longitudinal study of triple-transgenic mice for Alzheimer’s disease. J Alzheimers Dis43, 213–226.
90.
VidaC, Martinez de TodaI, GarridoA, CarroE, MolinaJA, De la FuenteM (2018) Impairment of several immune functions and redox state in blood cells of Alzheimer’s patients. Relevant role of neutrophils in the oxidative stress. Front Immunol8, 1974–1790.
91.
Martinez de TodaI, MuiguélezL, VidaC, CarroE, De la FuenteM (2019) Altered redox state in whole blood cells from patients with mild cognitive impairment and Alzheimer disease. J Alzheimers Dis71, 153–163.
GrochowskaM, LaskusT, RadkowskiM (2019) Gut microbiota in neurological disorders. Arch Immunol Ther Exp67, 375–383.
94.
KhanMS, IkramM, ParkJS, ParkTJ, KimMO (2020) Gut microbiota, its role in induction of Alzheimer's disease pathology, and possible therapeutic interventions: Special focus on anthocyanins. Cells9, 853.
95.
SunM, MaK, WenJ, WangG, ZhangCh, LiQ, BaoX, WangH (2020) A review of the brain-gut-microbiota axis and the potential role of microbiota in Alzheimer’s disease. J Alzheimers Dis73, 849–865.
96.
HuX, WangT, JinF (2016) Alzheimer’s disease and gut microbiota. Sci China Life Sci59, 1006–1023.
PlutaR, Utamek-KoziotM, JanuszewskiS, CzuczwarSJ (2020) Gut microbiota and pro/prebiotics in Alzheimer's disease. Aging12, 5539–5550.
99.
KesikaP, SuganthyN, SivamaruthiBS, ChaiyasutCh (2021) Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease. Life Sci264, 118627.
100.
KimMS, KimY, ChoiH, KimW, ParkS, LeeD, KimDK, KimHJ, ChoiH, HyunDW, LeeJY, ChoiEY, LeeDS, BaeJW, Mook-JungI (2020) Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model. Gut69, 283–294.
101.
HonarpishehP, ReynoldsCR, Blasco ConesaMP, Moruno ManchonJF, PutluriN, BhattacharjeeMB, UrayamaA, McCulloughLD, GaneshBP (2020) Dysregulated gut homeostasis observed prior to the accumulation of the brain amyloid-beta in Tg2576 mice. Int J Mol Sci21, 1711.
102.
MaccioniRB, NavarreteLP, GonzálezA, Gonzalez-CanacerA, Guzman-MartinezL, CortesN (2020) Inflammation: A major target for compounds to control Alzheimer’s disease. J Alzheimers Dis76, 1199–1213.
103.
JevticS, SengarAS, SalterMW, McLaurinJ (2017) The role of the immune system in Alzheimer disease: Etiology and treatment. Ageing Res Rev40, 84–94.
104.
PappollaMA, OmarRA, KimKS, RobakisNK (1992) Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am J Pathol140, 621–628.
BostancikliogluM (2019) The role of gut microbiota in pathogenesis of Alzheimer's disease. J Appl Microbiol127, 954–967.
107.
CattaneoA, CattaneN, GalluzziS, ProvasiS, LopizzoN, FestariC, FerrariC, GuerraUP, PagheraB, MuscioC, BianchettiA, VoltaGD, TurlaM, CotelliMS, GennusoM, PrelleA, ZanettiO, LussignoliG, MirabileD, BellandiD, GentileS, BelottiG, VillaniD, HarachT, BolmontT, PadovaniA, BoccardiM, FrisoniGB; INDIA-FBP Group (2017) Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging49, 60–68.
108.
ZhaoY, JaberV, LukiwWJ (2017) Secretory products of the human GI tract microbiome and their potential impact on Alzheimer's disease (AD): Detection of lipopolysaccharide (LPS) in AD hippocampus. Front Cell Infect Microbiol7, 318.
109.
GiauVV, WuSY, JamerlanA, AnSSA, KimSY, HulmeJ (2018) Gut microbiota and their neuroinflammatory implications in Alzheimer’s disease. Nutrients10, E1765.
LombardiV C, De MeirleirKL, SubramanianK, NouraniSM, DagdaRK, DelaneySL, PalotasA (2018) Nutritional modulation of intestinal microbiota; future opportunities for prevention and treatment of neuroimmune and neuroinflammatory disease. J Nutr Biochem61, 1–16.
112.
JungesVM, ClossVE, NogueiraGM, GottliebMGV (2018) Crosstalk between gut microbiota and central nervous system: A focus on Alzheimer's disease. Curr Alzheimer Res15, 1179–1190.
113.
DaoifodeT, GiridharanVV, GenerosoJS, BhattiG, CollodelA, SchulzPE, ForlenzaOV, BarichelloT (2021) The impact of the microbiota-gut-brain axis on Alzheimer's disease patholphysiology, Pharmacol Res164, 105314–105338.
114.
ChyanYJ, PoeggelerB, OmarRA, ChainDG, FrangioneB, GhisoJ, PappollaMA (1999) Potent neuroprotective properties against the Alzheimer beta-amyloid by endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem274, 21937–21942.
115.
HillC, GuarnerF, ReidG, GibsonGR, MerensteinDJ, PotB, MorelliL, CananiRB, FlintHJ, SalminenS, CalderPC, SandersME (2014) Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol11, 506–514.
116.
KobayashiY, SugaharaH, ShimadaK, MitsuyamaE, KuharaT, YasuokaA, KondoT, AbeK, XiaoJZ (2017) Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease. Sci Rep7, 13510.
117.
WestfallS, LomisN, KahouliI, DiaSY, SinghSP, PrakashS (2017) Microbiome, probiotics and neurodegenerative diseases: Deciphering the gut brain axis.3769-3787. Cell Mol Life Sci74.
118.
VasquezEC, AiresR, TonAMM, AmorimFG (2020) New insights on the beneficial effects of the probiotic kefir on vascular dysfunction in cardiovascular and neurodegenerative diseases. Curr Pharm Des26, 3700–3710.
119.
HolmesA, FingerC, Morales-ScheihingD, LeeJ, McCulloughLD (2020) Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions. Trans Res226, 39–56.
120.
ClancyR (2003) Immunobiotics and the probiotic evolution. FEMS Immunol Med Microbiol38, 9–12.
121.
DinanTG, StantonC, CryanJF (2013) Psychobiotics: A novel class of psychotropic. Biol Psychiatry74, 720–6.
122.
SaadN, DelattreC, UrdaciM, SchmitterJM, BressollierP (2013) An overview of the last advances in probiotic and prebiotic field. LWT Food Sci Technol50, 1–16.
123.
AnsariF, PourjafarH, TabriziA, HomayouniA (2020) The effects of probiotics and prebiotics on mental disorders: A review on depression, anxiety, Alzheimer, and autism spectrum disorders. Curr Pharm Biotechnol21, 555–565.
124.
DivyashriG, KrishnaG, MuralidharaN, PrapullaSG (2015) Probiotic attributes, antioxidant, anti-inflammatory and neuromodulatory effects of Enterococcus faecium CFR 3003: in vitro and in vivo evidence. J Med Microbiol64, 1527–40.
125.
JeongJJ, KimKA, HwangYJ, HanMJ, KimDH (2016) Antiinflammaging effects of Lactobacillus brevis OW38 in aged mice. Benef Microbes7, 707–718.
126.
LeeJ, YangW, HostetlerA, SchultzN, SuckowMA, StewartKL, KimDD, KimHS (2016) Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice. BMC Microbiol16, 69.
127.
AzadMAK, SarkerM, WanD (2018) Immunomodulatory effects of probiotics on cytokine profiles. Biomed Res Int2018, 8063647.
128.
LinX, XiaY, WangG, XiongZ, ZhangH, LaiF, AiL (2018) Lactobacillus plantarum AR501 alleviates the oxidative stress of d-galactose-induced aging mice liver by upregulation of Nrf2-mediated antioxidant enzyme expression. J Food Sci83, 1990–1998.
129.
HunscheC, CrucesJ, De la Fuente M (2019) Improvement of redox state and functions of immune cells as well as of behavior response in aged mice after two weeks supplementation of fermented milk with probiotics. Curr Microbiol76, 1278–1289.
130.
KongY, OlejarKL, OnALW, ChelikaniV (2020) The potential of Lactobacillus spp. For modulating oxidative stress in the gastrointestinal tract. Antioxidants9, 610.
131.
SasmitaAO (2019) Modification of the gut microbiome to combat neurodegeneration. Rev Neurosci30, 795–805.
132.
BarbosaRSD, Vieira-CoelhoMA (2020) Probiotics and prebiotics: Focus on psychiatric disorders-a systematic review. Nutr Rev78, 437–450.
133.
KrügerJF, HillesheimE, PereiraACSN, CamargoCQ, RabitoEI (2020) Probiotics for dementia: A systematic review and meta-analysis of randomized controlled trials. Nutr Rev79, 160–170.
